101 related articles for article (PubMed ID: 2910300)
1. In vitro inhibition of hepatic steroid hydroxylation by tamoxifen, a series of tamoxifen analogues and related compounds.
Reidy GF; Murray M
Biochem Pharmacol; 1989 Jan; 38(1):195-9. PubMed ID: 2910300
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in the in vitro modulation of rat hepatic microsomal androst-4-ene-3,17-dione hydroxylase activities by derivatives of 5 alpha- and 5 beta-androstane.
Murray M; Mehta I
J Steroid Biochem; 1990 Mar; 35(3-4):465-71. PubMed ID: 2325413
[TBL] [Abstract][Full Text] [Related]
3. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
Murray M
Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
5. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
Murray M; Reidy GF
Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
7. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of 1-substituted imidazole and 1,2,4-triazole antifungal compounds as inhibitors of testosterone hydroxylations catalysed by mouse hepatic microsomal cytochromes P-450.
Ballard SA; Lodola A; Tarbit MH
Biochem Pharmacol; 1988 Dec; 37(24):4643-51. PubMed ID: 3202901
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
Murray M; Field SL
Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
[TBL] [Abstract][Full Text] [Related]
10. Comparative inhibition of inducible and constitutive CYPs in rat hepatic microsomes by parathion.
Murray M; Butler AM
Xenobiotica; 2004 Aug; 34(8):723-39. PubMed ID: 15690761
[TBL] [Abstract][Full Text] [Related]
11. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
Murray M
Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
[TBL] [Abstract][Full Text] [Related]
12. Hepatic microsomal metabolism of androst-4-ene-3,17-dione: relative importance of ring hydroxylation and aromatization in control and induced rat liver.
Murray M; Cantrill E; Farrell GC
J Steroid Biochem; 1988 Feb; 29(2):233-7. PubMed ID: 3347063
[TBL] [Abstract][Full Text] [Related]
13. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
Stevens JC; Halpert J
Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of hepatic drug oxidation by thioridazine. Kinetic analysis of the inhibition of cytochrome P-450 isoform-specific reactions.
Murray M; Reidy GF
Biochem Pharmacol; 1989 Dec; 38(24):4359-65. PubMed ID: 2604739
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycin.
Stupans I; Sansom LN
Biochem Pharmacol; 1991 Nov; 42(11):2085-90. PubMed ID: 1958226
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatic drug metabolism by phenothiazine tranquilizers: quantitative structure-activity relationships and selective inhibition of cytochrome P-450 isoform-specific activities.
Murray M
Chem Res Toxicol; 1989; 2(4):240-6. PubMed ID: 2577523
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice.
White IN; Davies A; Smith LL; Dawson S; De Matteis F
Biochem Pharmacol; 1993 Jan; 45(1):21-30. PubMed ID: 8424814
[TBL] [Abstract][Full Text] [Related]
20. The involvement of cytochrome P-450 in hepatic microsomal steroid hydroxylation reactions supported by sodium periodate, sodium chlorite, and organic hydroperoxides.
Hrycay EG; Gustafsson JA; Ingelman-Sundberg M; Ernster L
Eur J Biochem; 1976 Jan; 61(1):43-52. PubMed ID: 173555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
